Jia Lu - Innovent Biologics (Suzhou) Co

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 8 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract LB057: Pre-clinical Characterization of IBI343, a Site-Specifically Conjugated Anti-Claundin18.2 ADC, for Treating Solid Tumors

Shuaixiang Zhou, Xiong Yao, Jian Guan,Keke Fei,Jia Lu,Weiwei Wu, Yang Liu, Tianyu Zhu, Zhuangguang Liao, Shi Chen,Bingliang Chen,Kaijie He

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Abstract LB055: IBI3001: A Potentially First-in-class Site-Specifically Conjugated B7-H3/EGFR Bispecific ADC for Multiple Solid Tumors

Jian Guan, Xiao Zhang, Weiwei Wu, Lei Cao, Zhengguang Liao, Tianyu Zhu, Chentao Liu, Shuaixiang Zhou,Lu Jia, Ninghuan Li, Nana Luo, Ying Zhang, Dian Kang, Tiong Sun Chia, Bingliang Chen, Kaijie He

Cancer Researchno. 7_Supplement (2024): LB055-LB055

引用0浏览0引用

Abstract LB055: IBI3001: A potentially first-in-class site-specifically conjugated B7-H3/EGFR bispecific ADC for multiple solid tumors

Jian Guan, Xiao Zhang,Weiwei Wu, Lei Cao, Zhengguang Liao, Tianyu Zhu, Chentao Liu,Shuaixiang Zhou,Jia Lu, Ninghuan Li,Nana Luo, Ying Zhang, Kang Dian,Tiong Sun Chia,Bingliang Chen,Kaijie He

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

IBI3001: A Potentially First-in-class Site-Specifically Conjugated B7H3/EGFR Bispecific ADC for Multiple Solid Tumors